Product Description: MS417 is a selective BET-specific BRD4 inhibitor, binds to BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively, with weak selectivity at CBP BRD (IC50, 32.7 μM).
Applications: COVID-19-anti-virus
Formula: C20H19ClN4O2S
References: [1]Zhang G, et al. Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. J Biol Chem. 2012 Aug 17;287(34):28840-51.
CAS Number: 916489-36-6
Molecular Weight: 414.91
Compound Purity: 99.79
Research Area: Infection; Inflammation/Immunology
Solubility: 10 mM in DMSO/Ethanol : 50 mg/mL (ultrasonic)
Target: Epigenetic Reader Domain;HIV